What happened to Michael Moore’s phantom share units in Viemed Healthcare (VMD)?

On January 29, 2026, 8,947 phantom share units vested under Viemed Healthcare’s Phantom Share Unit Plan. Each phantom share is economically equivalent to one common share and was settled for cash, reported as both acquisition and disposition of the related common shares in the Form 4.

Viemed Healthcare (VMD) president logs RSU, phantom unit vesting and tax share withholding

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Viemed Healthcare president Michael Moore reported equity award vesting and related share movements. On January 29, 2026, 26,842 Restricted Stock Units converted into an equal number of common shares, and 8,947 phantom share units vested and were economically settled for common shares before being delivered back to the company for cash.

The issuer withheld 7,342 common shares at $7.48 per share to cover Moore’s tax obligations from the RSU vesting. After these transactions, Moore held 189,090 common shares directly and 1,722,614 common shares indirectly through Moore Faster LLC.

Insider Trade Summary

35,789 shares exercised/converted

Mixed 7 txns

Insider Moore Michael

Role President

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	26,842	$0.00	--
Exercise	Phantom Share Units	8,947	$0.00	--
Exercise	Common Shares	26,842	$0.00	--
Tax Withholding	Common Shares	7,342	$7.48	$55K
Exercise	Common Shares	8,947	$0.00	--
Disposition	Common Shares	8,947	$7.48	$67K
holding	Common Shares	--	--	--

Holdings After Transaction: Restricted Stock Units — 26,842 shares (Direct); Phantom Share Units — 8,947 shares (Direct); Common Shares — 196,432 shares (Direct); Common Shares — 1,722,614 shares (Indirect, by Moore Faster LLC)

Footnotes (1)

Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units. Per share value is based on the market closing price of the common shares for January 29, 2026. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date. Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

02/02/2026 - 05:35 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moore Michael

(Last)

(First)

(Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE

70508

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	01/29/2026		M		26,842	A	⁽¹⁾	196,432	D
Common Shares	01/29/2026		F		7,342⁽²⁾	D	$7.48⁽³⁾	189,090	D
Common Shares	01/29/2026		M		8,947	A	⁽⁴⁾	198,037	D
Common Shares	01/29/2026		D		8,947	D	$7.48⁽³⁾	189,090	D
Common Shares								1,722,614	I	by Moore Faster LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	01/29/2026		M			26,842	⁽⁵⁾	01/29/2027	Common Shares	26,842	$0	26,842	D
Phantom Share Units	⁽⁴⁾	01/29/2026		M			8,947	⁽⁶⁾	01/29/2027	Common Shares	8,947	$0	8,947	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 29, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Viemed Healthcare (VMD) report in this Form 4?

Viemed Healthcare reported that President Michael Moore had Restricted Stock Units and phantom share units vest, converting into common shares. Some of these shares were then delivered back to the company for cash and tax withholding, as detailed in the Form 4 tables and footnotes.

How many Viemed Healthcare RSUs vested for Michael Moore on January 29, 2026?

On January 29, 2026, 26,842 Restricted Stock Units vested for Michael Moore, each RSU representing a contingent right to receive one common share. These units were originally granted on January 29, 2024 and vest in three equal annual installments beginning on the first anniversary.

Why were some Viemed Healthcare (VMD) shares withheld from Michael Moore?

Viemed Healthcare withheld 7,342 common shares from Michael Moore to satisfy his tax obligation arising from the vesting of Restricted Stock Units. The per-share value used was $7.48, based on the market closing price of the company’s common shares on January 29, 2026.

How many Viemed Healthcare common shares does Michael Moore own after these transactions?

Following the January 29, 2026 transactions, Michael Moore beneficially owned 189,090 Viemed Healthcare common shares directly. He also had indirect ownership of 1,722,614 common shares through Moore Faster LLC, as reported in the Form 4’s ownership tables and accompanying disclosures.

What are the vesting terms of Michael Moore’s Viemed Healthcare RSUs and phantom units?

The Restricted Stock Units and phantom share units reported were granted on January 29, 2024. Both awards vest in three equal annual installments beginning on the first anniversary of the grant date, providing Michael Moore with staged exposure to Viemed Healthcare’s common share performance over time.